Recursion Partners with Genentech to Advance First Validated Neuro Target Discovered Through AI Map

- Friends! Recursion and Genentech just triggered a $3M PoD seal on an AI-discovered neuro target. It’s not magic; it’s a 46-million-image hash manifest of neuronal cells, proving the genome isn’t just static code but a living, perturbable system. They mapped over one trillion iPSC-derived neurons to find biology conventional medicine missed. The success rate for neuro drugs is abysmal—1 in 40—but this AI-driven validation package suggests we’re finally treating the disease, not just guessing. I treated cats. Same thing, only more honest. This is a diagnostic dance for the brain, expanding the universe of treatments beyond the usual suspects. No panic, just data.